{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:15:30Z","timestamp":1789787730663,"version":"4.0.1"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"China Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["T-B-124"],"award-info":[{"award-number":["T-B-124"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109051","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:39:59Z","timestamp":1759282799000},"page":"109051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Advances in targeting glycogen synthase kinase 3\u03b2 for diabetes therapy"],"prefix":"10.1016","volume":"166","author":[{"given":"Fuyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyou","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109051_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109051_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2025.109051_bb0015","series-title":"Nursing standard (Royal college of nursing (Great Britain) : 1987)","first-page":"61","article-title":"Diabetes mellitus: an overview of the types, symptoms, complications and management","volume":"37","author":"Cloete","year":"2022"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051770","article-title":"Insulin: the friend and the foe in the development of type 2 diabetes mellitus","volume":"21","author":"Rachdaoui","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109051_bb0025","series-title":"Insulin sources and types: a review of insulin in terms of its mode on diabetes mellitus, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","first-page":"234","volume":"34","author":"Ahmad","year":"2014"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"European J. Biochem."},{"key":"10.1016\/j.bioorg.2025.109051_bb0035","series-title":"Recent advances in understanding the cellular roles of GSK-3","author":"Cormier","year":"2017"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0040","article-title":"GSK3\u03b2: a ray of hope for the treatment of diabetic kidney disease, FASEB journal : official publication of the Federation of American Societies for","volume":"38","author":"Liang","year":"2024","journal-title":"Exp. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109051_bb0045","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1097\/MS9.0000000000002712","article-title":"Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review","volume":"86","author":"Joshi","year":"2012","journal-title":"Annals Med. Surgery"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer\u2019s disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109051_bb0055","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","article-title":"Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation","volume":"118","author":"Kerkela","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2025.109051_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-213X-7-93","article-title":"Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo","volume":"7","author":"Lee","year":"2007","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.bioorg.2025.109051_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1051\/parasite\/2019038","article-title":"Molecular cloning and transcriptional and functional analysis of glycogen synthase kinase-3\u03b2 in Haemaphysalis longicornis (Acari, Ixodidae)","volume":"26","author":"Rahman","year":"2019","journal-title":"Parasite (Paris, France)"},{"key":"10.1016\/j.bioorg.2025.109051_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"25","key":"10.1016\/j.bioorg.2025.109051_bb0075","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2174\/138161210793176581","article-title":"Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Medina","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.109051_bb0080","doi-asserted-by":"crossref","first-page":"4209475","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109051_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169098","article-title":"GSK-3\u03b2, FYN, and DYRK1A: master regulators in neurodegenerative pathways","volume":"22","author":"Demuro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109051_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/89624","article-title":"Structure of GSK3beta reveals a primed phosphorylation mechanism","volume":"8","author":"ter Haar","year":"2001","journal-title":"Nat. Struct. Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400160","article-title":"Limonoids isolated from Chisocheton ceramicus Miq. And the antiadipogenic mechanism of action of ceramicine B","volume":"357","author":"Bailly","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109051_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114301","article-title":"Development of inhibitors targeting glycogen synthase kinase-3\u03b2 for human diseases: strategies to improve selectivity","volume":"236","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/1873-3468.12995","article-title":"Glycogen synthase kinase-3\u03b2 regulation: another kinase gets in on the AKT","volume":"592","author":"Turk","year":"2018","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0115","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation","volume":"7","author":"Frame","year":"2001","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/emboj\/cdg068","article-title":"Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex","volume":"22","author":"Dajani","year":"2003","journal-title":"EMBO J."},{"issue":"4\u20135","key":"10.1016\/j.bioorg.2025.109051_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2025.109051_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100779","article-title":"GSK3\u03b2 as a novel promising target to overcome chemoresistance in pancreatic cancer","volume":"58","author":"Pecoraro","year":"2021","journal-title":"Drug Resistance Updates : Rev. Commentaries Antimicrobial Anticancer Chemotherapy"},{"issue":"29","key":"10.1016\/j.bioorg.2025.109051_bb0135","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1016\/S0021-9258(18)47901-X","article-title":"Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3","volume":"262","author":"Fiol","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2025.109051_bb0140","first-page":"1","article-title":"GSK3 takes Centre stage more than 20 years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. J."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2025.109051_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj20031259","article-title":"Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event","volume":"377","author":"Cole","year":"2004","journal-title":"Biochem. J."},{"issue":"Pt 7","key":"10.1016\/j.bioorg.2025.109051_bb0150","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0160","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1038\/s41598-017-09239-5","article-title":"In vivo regulation of glycogen synthase kinase 3\u03b2 activity in neurons and brains","volume":"7","author":"Krishnankutty","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"51","key":"10.1016\/j.bioorg.2025.109051_bb0170","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1021\/bi100822q","article-title":"Allosteric regulation of glycogen synthase kinase 3\u03b2: a theoretical study","volume":"49","author":"Buch","year":"2010","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/07391102.2018.1426043","article-title":"Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3\u03b2","volume":"37","author":"Kumar","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109051_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158252","article-title":"Revisiting the proposition of binding pockets and bioactive poses for GSK-3\u03b2 allosteric modulators addressed to neurodegenerative diseases","volume":"22","author":"Silva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109051_bb0185","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/jm200996g","article-title":"Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities","volume":"54","author":"Palomo","year":"2011","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109051_bb0190","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.3390\/molecules19079134","article-title":"Investigation of the flexibility of protein kinases implicated in the pathology of Alzheimer\u2019s disease","volume":"19","author":"Mazanetz","year":"2014","journal-title":"Mol. (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.109051_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106456","article-title":"Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3\u03b1 (GSK-3\u03b1): development and impact on temozolomide treatment of glioblastoma cells","volume":"134","author":"Hasyeoui","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochimica et Biophysica acta. Mol. Cell Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb0205","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1080\/15548627.2019.1687212","article-title":"STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I","volume":"16","author":"Zhou","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2025.109051_bb0210","doi-asserted-by":"crossref","first-page":"38553","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0215","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: revisiting glycogen synthase kinase-3\u03b2 as a target for the treatment of Cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res. : Official J. Am. Assoc. Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb0220","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cellsig.2006.06.006","article-title":"GSK-3beta regulation in skeletal muscles by adrenaline and insulin: evidence that PKA and PKB regulate different pools of GSK-3","volume":"19","author":"Jensen","year":"2007","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","article-title":"GSK3: a multifaceted kinase in Wnt signaling","volume":"35","author":"Wu","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bioorg.2025.109051_bb0235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2020.12.018","article-title":"Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3\u03b2-mediated oxidative stress and IRE1\u03b1\/TRAF2\/JNK pathway","volume":"163","author":"Xu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-020-0111-4","article-title":"Silencing MYH9 blocks HBx-induced GSK3\u03b2 ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma","volume":"5","author":"Lin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"37","key":"10.1016\/j.bioorg.2025.109051_bb0245","doi-asserted-by":"crossref","first-page":"39493","DOI":"10.18632\/oncotarget.6303","article-title":"The redox sensitive glycogen synthase kinase 3\u03b2 suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.109051_bb0250","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1038\/ncomms7765","article-title":"Glycogen synthase kinase 3\u03b2 ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production","volume":"6","author":"Ko","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb0255","doi-asserted-by":"crossref","first-page":"18856","DOI":"10.3390\/ijms151018856","article-title":"Computer-aided targeting of the PI3K\/Akt\/mTOR pathway: toxicity reduction and therapeutic opportunities","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109051_bb0260","doi-asserted-by":"crossref","first-page":"1586927","DOI":"10.1155\/2016\/1586927","article-title":"Atypical diabetic foot ulcer keratinocyte protein signaling correlates with impaired wound healing","volume":"2016","author":"Hoke","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109051_bb0265","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1242\/dev.137075","article-title":"Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination","volume":"143","author":"Yu","year":"2016","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0270","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-014-1803-3","article-title":"Current clinical regulation of PI3K\/PTEN\/Akt\/mTOR signalling in treatment of human cancer","volume":"141","author":"Lim","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0275","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3892\/mmr.2014.2819","article-title":"Regulation of the cell cycle and PI3K\/Akt\/mTOR signaling pathway by tanshinone I in human breast cancer cell lines","volume":"11","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0280","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/odi.12070","article-title":"Exploiting PI3K\/mTOR signaling to accelerate epithelial wound healing","volume":"19","author":"Castilho","year":"2013","journal-title":"Oral Dis."},{"key":"10.1016\/j.bioorg.2025.109051_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","article-title":"Diabetes mellitus and Alzheimer's disease: GSK-3\u03b2 as a potential link","volume":"339","author":"Zhang","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0290","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3892\/ol.2014.2608","article-title":"mTOR pathway: a current, up-to-date mini-review (review)","volume":"8","author":"Zarogoulidis","year":"2014","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0295","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0300","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1074\/jbc.M004812200","article-title":"Regulation of glycogen synthesis by amino acids in cultured human muscle cells","volume":"276","author":"Armstrong","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0310","first-page":"7","article-title":"Effects of PI3K\/Akt pathway in wound healing process of mice skin","volume":"32","author":"Gao","year":"2016","journal-title":"Fa Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0315","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170658","article-title":"Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K\/Akt\/mTOR signaling pathway","volume":"37","author":"Xiao","year":"2017","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0320","doi-asserted-by":"crossref","first-page":"15260","DOI":"10.3390\/ijms140815260","article-title":"The role of AKT\/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence","volume":"14","author":"Strozyk","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109051_bb0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2019.03.001","article-title":"Role of the PI3K\/AKT (mTOR and GSK3\u03b2) signalling pathway and photobiomodulation in diabetic wound healing","volume":"50","author":"Jere","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026340","article-title":"PI3K-dependent GSK3\u00df(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response","volume":"6","author":"Karrasch","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0335","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/febs.12059","article-title":"Regulation of glycogen synthase from mammalian skeletal muscle--a unifying view of allosteric and covalent regulation","volume":"280","author":"Palm","year":"2013","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.111.187427","article-title":"Impaired wound healing in hypoxic renal tubular cells: roles of hypoxia-inducible factor-1 and glycogen synthase kinase 3\u03b2\/\u03b2-catenin signaling","volume":"340","author":"Peng","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.416","article-title":"Increase in the radioresistance of normal skin fibroblasts but not tumor cells by mechanical injury","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036974","article-title":"Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial","volume":"7","author":"Lima","year":"2012","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0355","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527312666131223113900","article-title":"Wnt\/\u03b2-catenin signaling in Alzheimer\u2019s disease","volume":"13","author":"De Ferrari","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0370","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1242\/dev.01117","article-title":"LDL receptor-related proteins 5 and 6 in Wnt\/beta-catenin signaling: arrows point the way","volume":"131","author":"He","year":"2004","journal-title":"Development"},{"issue":"Pt 3","key":"10.1016\/j.bioorg.2025.109051_bb0375","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem. J."},{"issue":"34","key":"10.1016\/j.bioorg.2025.109051_bb0380","doi-asserted-by":"crossref","first-page":"35503","DOI":"10.1074\/jbc.M402937200","article-title":"Wnt10b inhibits development of white and brown adipose tissues","volume":"279","author":"Longo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0390","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/db17-0318","article-title":"The diabetes gene and Wnt pathway effector TCF7L2 regulates adipocyte development and function","volume":"67","author":"Chen","year":"2018","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109051_bb0395","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1111\/jcmm.16663","article-title":"The complex role of Wnt ligands in type 2 diabetes mellitus and related complications","volume":"25","author":"Nie","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109051_bb0400","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ncb1647","article-title":"A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation","volume":"9","author":"Takada","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040115","article-title":"Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context","volume":"4","author":"Mikels","year":"2006","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0410","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ceb.2007.09.014","article-title":"Wnt\/beta-catenin signaling in adipogenesis and metabolism","volume":"19","author":"Prestwich","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0415","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.18632\/aging.102702","article-title":"Chikusetsu saponin IVa protects pancreatic \u03b2 cell against intermittent high glucose-induced injury by activating Wnt\/\u03b2-catenin\/TCF7L2 pathway","volume":"12","author":"Cui","year":"2020","journal-title":"Aging"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109051_bb0420","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1073\/pnas.0701509104","article-title":"Wnt signaling regulates pancreatic beta cell proliferation","volume":"104","author":"Rulifson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7830","key":"10.1016\/j.bioorg.2025.109051_bb0425","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109051_bb0430","series-title":"Wnt-signalling and the metabolic syndrome, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","first-page":"159","volume":"41","author":"Schinner","year":"2009"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0435","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"Kato","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bioorg.2025.109051_bb0440","series-title":"New Insights into the Role and Mechanism of Wnt\/\u03b2-Catenin Signalling in Kidney Fibrosis, Nephrology (Carlton, Vic.)","first-page":"38","volume":"vol. 23","author":"Zuo","year":"2018"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/genes11050496","article-title":"The role of Wnt Signalling in chronic kidney disease (CKD)","volume":"11","author":"Malik","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.bioorg.2025.109051_bb0450","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.03.022","article-title":"Protective or deleterious role of Wnt\/beta-catenin signaling in diabetic nephropathy: an unresolved issue","volume":"144","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0455","doi-asserted-by":"crossref","first-page":"F549","DOI":"10.1152\/ajprenal.00566.2009","article-title":"Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes","volume":"300","author":"Babayeva","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0460","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000515041","article-title":"Indoleamine-2,3-dioxygenase activates Wnt\/\u03b2-catenin inducing kidney fibrosis after acute kidney injury","volume":"67","author":"Pan","year":"2021","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0465","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00018-022-04213-5","article-title":"S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3\u03b2 and CK1\u03b1","volume":"79","author":"Sun","year":"2022","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.bioorg.2025.109051_bb0470","article-title":"The Wnt signaling pathway in diabetic nephropathy","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Develop.Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0475","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188316","article-title":"Long non-coding RNAs and nuclear factor-\u03baB crosstalk in cancer and other human diseases","volume":"1873","author":"Gupta","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.109051_bb0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109051_bb0490","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.omtn.2019.11.007","article-title":"Nuclear factor \u03baB signaling and its related non-coding RNAs in Cancer therapy","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Therapy. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0495","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2016.03.002","article-title":"Noncanonical NF-\u03baB signaling in health and disease","volume":"22","author":"Cildir","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0505","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molmed.2019.02.005","article-title":"NIK as a Druggable mediator of tissue injury","volume":"25","author":"Vali\u00f1o-Rivas","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb0510","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"49","key":"10.1016\/j.bioorg.2025.109051_bb0515","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1038\/s41388-019-0958-4","article-title":"MALT1 is a critical mediator of PAR1-driven NF-\u03baB activation and metastasis in multiple tumor types","volume":"38","author":"McAuley","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00018-015-2059-z","article-title":"The paracaspase MALT1: biological function and potential for therapeutic inhibition","volume":"73","author":"Jaworski","year":"2016","journal-title":"Cell. Mol. Life Sci.\u202f: CMLS"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0525","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/adip.20235","article-title":"The GSK-3\u03b2\/Fyn\/Nrf2 pathway in fibroblasts and wounds of type 2 diabetes: on the road to an evidence-based therapy of non-healing wounds","volume":"1","author":"Bitar","year":"2012","journal-title":"Adipocyte"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.kint.2019.08.036","article-title":"Glycogen synthase kinase 3\u03b2 hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease","volume":"97","author":"Liang","year":"2020","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0535","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-018-0295-z","article-title":"GSK3\u03b2-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions","volume":"13","author":"Zhu","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"2019","key":"10.1016\/j.bioorg.2025.109051_bb0540","first-page":"874","article-title":"Multiple organ injury in male C57BL\/6J mice exposed to ambient particulate matter in a real-ambient PM exposure system in Shijiazhuang, China","volume":"248","author":"Li","year":"1987","journal-title":"Env. Pollution Barking Essex"},{"key":"10.1016\/j.bioorg.2025.109051_bb0545","article-title":"Gegen Qinlian decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways","volume":"126","author":"Zhang","year":"2020","journal-title":"Biomed. & Pharmacotherapy = Biomed. & Pharmacotherapie"},{"key":"10.1016\/j.bioorg.2025.109051_bb0550","first-page":"2853534","article-title":"Salvianolic acid a protects the kidney against oxidative stress by activating the Akt\/GSK-3\u03b2\/Nrf2 signaling pathway and inhibiting the NF-\u03baB signaling pathway in 5\/6 Nephrectomized rats","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0555","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhep.2018.01.036","article-title":"Glycogen synthase kinase 3\u03b2 promotes liver innate immune activation by restraining AMP-activated protein kinase activation","volume":"69","author":"Zhou","year":"2018","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0560","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/acs.molpharmaceut.0c00177","article-title":"Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing","volume":"17","author":"Lv","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2025.109051_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104794","article-title":"Targeting the \u03b2-catenin signaling for cancer therapy","volume":"160","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0570","first-page":"151","article-title":"Lucidone promotes the cutaneous wound healing process via activation of the PI(3)K\/AKT, Wnt\/\u03b2-catenin and NF-\u03baB signaling pathways, Biochimica et biophysica acta","volume":"1864","author":"Yang","year":"2017","journal-title":"Mol. Cell Res."},{"key":"10.1016\/j.bioorg.2025.109051_bb0575","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fphar.2019.00523","article-title":"Sodium Dichloroacetate stimulates angiogenesis by improving endothelial precursor cell function in an AKT\/GSK-3\u03b2\/Nrf2 dependent pathway in vascular dementia rats","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb0580","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1096\/fj.201701543RR","article-title":"Angiotensin II increases angiogenesis by NF-\u03baB-mediated transcriptional activation of angiogenic factor AGGF1","volume":"32","author":"Si","year":"2018","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0585","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12964-019-0376-9","article-title":"Elevated Kallikrein-binding protein in diabetes impairs wound healing through inducing macrophage M1 polarization","volume":"17","author":"Feng","year":"2019","journal-title":"Cell Commun. Signal. : CCS"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109051_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118696","article-title":"GSK3 and miRNA in neural tissue: from brain development to neurodegenerative diseases","volume":"1867","author":"Gizak","year":"2020","journal-title":"Biochimica et Biophysica acta. Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0595","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s12035-016-0359-4","article-title":"Regulation of miR-34 family in neuronal development","volume":"55","author":"Jauhari","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-019-1059-5","article-title":"MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res : CR"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0605","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jid.2019.07.694","article-title":"MicroRNA-34 family enhances wound inflammation by targeting LGR4","volume":"140","author":"Wu","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0610","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0615","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"Suzuki","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0620","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/bio.20134853","article-title":"Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration","volume":"2","author":"Holmstr\u00f6m","year":"2013","journal-title":"Biol. Open"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109051_bb0625","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0630","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109051_bb0635","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1089\/ars.2010.3222","article-title":"Discovery of the negative regulator of Nrf2, Keap1: a historical overview","volume":"13","author":"Itoh","year":"2010","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0640","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109051_bb0645","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109051_bb0650","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","article-title":"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase","volume":"24","author":"Cullinan","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109051_bb0655","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0660","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1134\/S0006297913010033","article-title":"Keap1\/Nrf2\/ARE redox-sensitive signaling system as a pharmacological target, biochemistry","volume":"78","author":"Zenkov","year":"2013","journal-title":"Biokhimiia"},{"issue":"18","key":"10.1016\/j.bioorg.2025.109051_bb0665","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"44","key":"10.1016\/j.bioorg.2025.109051_bb0670","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109051_bb0675","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.freeradbiomed.2007.03.001","article-title":"Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2","volume":"42","author":"Pi","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109051_bb0680","doi-asserted-by":"crossref","first-page":"12475","DOI":"10.1073\/pnas.220418997","article-title":"Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2","volume":"97","author":"Huang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"45","key":"10.1016\/j.bioorg.2025.109051_bb0685","doi-asserted-by":"crossref","first-page":"44675","DOI":"10.1074\/jbc.M307633200","volume":"278","author":"Bloom","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.bioorg.2025.109051_bb0690","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1074\/jbc.M206911200","article-title":"Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0695","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0700","doi-asserted-by":"crossref","first-page":"C334","DOI":"10.1152\/ajpcell.00043.2003","article-title":"Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress","volume":"285","author":"Numazawa","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109051_bb0705","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1128\/MCB.23.20.7198-7209.2003","article-title":"Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival","volume":"23","author":"Cullinan","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0710","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbt.20212","article-title":"Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells","volume":"22","author":"Apopa","year":"2008","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109051_bb0715","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M611336200","article-title":"GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2","volume":"282","author":"Jain","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.bioorg.2025.109051_bb0720","doi-asserted-by":"crossref","first-page":"28821","DOI":"10.1074\/jbc.M111.255042","article-title":"Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression","volume":"286","author":"Niture","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0725","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2011.11.003","article-title":"Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: role of glycogen synthase kinase-3","volume":"52","author":"Rojo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"Pt B","key":"10.1016\/j.bioorg.2025.109051_bb0730","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2015.04.029","article-title":"Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3\/\u03b2-TrCP","volume":"88","author":"Cuadrado","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0735","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BST20150011","article-title":"Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of \u03b2-TrCP and GSK-3","volume":"43","author":"Hayes","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bioorg.2025.109051_bb0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: functional insights from cell biology and animal models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0745","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2013.04.022","article-title":"Activator or inhibitor? GSK-3 as a new drug target","volume":"86","author":"Takahashi-Yanaga","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0750","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcn.2008.06.007","article-title":"Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death","volume":"39","author":"Rojo","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109051_bb0755","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","article-title":"Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2","volume":"281","author":"Salazar","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109051_bb0760","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/MCB.25.11.4501-4513.2005","article-title":"Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism","volume":"25","author":"Velichkova","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bioorg.2025.109051_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101275","article-title":"GSK3\u03b2-mediated Keap1-independent regulation of Nrf2 antioxidant response: a molecular rheostat of acute kidney injury to chronic kidney disease transition","volume":"26","author":"Lu","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2025.109051_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153856","article-title":"Moringa oleifera Lam. Seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3\u03b2 activity and activating the Nrf2\/HO-1 pathway","volume":"95","author":"Wen","year":"2022","journal-title":"Phytomed : Int. J. Phytotherapy Phytopharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0775","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2025.109051_bb0780","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109051_bb0785","doi-asserted-by":"crossref","first-page":"7643","DOI":"10.1073\/pnas.0602558103","article-title":"Structure of the ternary signaling complex of a TGF-beta superfamily member","volume":"103","author":"Allendorph","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0790","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-beta superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0795","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0800","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","article-title":"Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction","volume":"107","author":"Dobaczewski","year":"2010","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb0805","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109051_bb0810","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yjmcc.2017.07.011","article-title":"Entanglement of GSK-3\u03b2, \u03b2-catenin and TGF-\u03b21 signaling network to regulate myocardial fibrosis","volume":"110","author":"Guo","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0815","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cas.13922","article-title":"Phosphorylation status at Smad3 linker region modulates transforming growth factor-\u03b2-induced epithelial-mesenchymal transition and cancer progression","volume":"110","author":"Ooshima","year":"2019","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0820","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2011.09.012","article-title":"Wnt\/\u03b2-catenin pathway forms a negative feedback loop during TGF-\u03b21 induced human normal skin fibroblast-to-myofibroblast transition","volume":"65","author":"Liu","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0825","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2012.06.004","article-title":"TGF-beta1 increases cell rigidity by enhancing expression of smooth muscle actin: keloid-derived fibroblasts as a model for cellular mechanics","volume":"67","author":"Lee","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0830","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jdermsci.2014.03.002","article-title":"A novel small compound accelerates dermal wound healing by modifying infiltration, proliferation and migration of distinct cellular components in mice","volume":"74","author":"Yamaoka","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0835","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdermsci.2012.11.009","article-title":"Thy-1 knockdown retards wound repair in mouse skin","volume":"69","author":"Lee","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0840","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jdermsci.2013.10.009","article-title":"TLR4, rather than TLR2, regulates wound healing through TGF-\u03b2 and CCL5 expression","volume":"73","author":"Suga","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"25","key":"10.1016\/j.bioorg.2025.109051_bb0845","doi-asserted-by":"crossref","first-page":"17934","DOI":"10.1074\/jbc.274.25.17934","article-title":"The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism","volume":"274","author":"Summers","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb0850","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1358\/dnp.2003.16.9.829337","article-title":"Glycogen synthase kinase-3 as drug target: from wallflower to center of attention","volume":"16","author":"Van Wauwe","year":"2003","journal-title":"Drug News Perspect."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0855","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"42","key":"10.1016\/j.bioorg.2025.109051_bb0860","doi-asserted-by":"crossref","first-page":"32475","DOI":"10.1074\/jbc.M005342200","article-title":"Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling","volume":"275","author":"Ding","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0865","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2337\/diabetes.48.8.1662","article-title":"Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL\/6J mice","volume":"48","author":"Eldar-Finkelman","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2025.109051_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117406","article-title":"Glycogen synthase kinase-3: a potential target for diabetes","volume":"92","author":"Teli","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0875","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/en.2003-1522","article-title":"Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer\u2019s disease regulates insulin gene transcription in pancreatic beta-cells","volume":"145","author":"Ubeda","year":"2004","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0880","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","article-title":"Glycogen synthase kinase 3: an emerging therapeutic target","volume":"8","author":"Eldar-Finkelman","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0885","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb0890","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3349\/ymj.2017.58.3.479","article-title":"Metabolism-centric overview of the pathogenesis of Alzheimer's disease","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb0895","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0900","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109051_bb0905","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.1817391116","article-title":"Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior","volume":"116","author":"Soto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0910","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in insulin and insulin signaling in Alzheimer\u2019s disease: cause or consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0915","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmet.2016.06.011","article-title":"Insulin in the nervous system and the mind: functions in metabolism, memory, and mood","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metabolism"},{"key":"10.1016\/j.bioorg.2025.109051_bb0920","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bioorg.2025.109051_bb0925","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fnagi.2018.00227","article-title":"Evaluation of metformin on cognitive improvement in patients with non-dementia vascular cognitive impairment and abnormal glucose metabolism","volume":"10","author":"Lin","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0930","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb0935","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/cas.13028","article-title":"Glycogen synthase kinase-3\u03b2 is a pivotal mediator of cancer invasion and resistance to therapy","volume":"107","author":"Domoto","year":"2016","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0940","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0945","first-page":"801","article-title":"Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling, cancer prevention research","volume":"vol. 6","author":"Quinn","year":"2013","journal-title":"Philadelphia, Pa"},{"issue":"21","key":"10.1016\/j.bioorg.2025.109051_bb0950","first-page":"2593","article-title":"Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial, journal of clinical oncology\u202f: official journal of the American society of","volume":"30","author":"Bonanni","year":"2012","journal-title":"Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb0955","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-014-3141-1","article-title":"Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial","volume":"148","author":"DeCensi","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0960","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1172\/JCI89914","article-title":"Metabolic shifts in residual breast cancer drive tumor recurrence","volume":"127","author":"Havas","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb0965","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1074\/jbc.M111.306472","article-title":"Evidence for irreversible inhibition of glycogen synthase kinase-3\u03b2 by tideglusib","volume":"287","author":"Dom\u00ednguez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0970","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10637-015-0278-7","article-title":"A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin","volume":"33","author":"Gray","year":"2015","journal-title":"Invest. New Drugs"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109051_bb0975","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3109\/10428194.2015.1122781","article-title":"An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia","volume":"57","author":"Rizzieri","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb0980","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molcel.2004.08.010","article-title":"Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation","volume":"15","author":"Ha","year":"2004","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109051_bb0985","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","article-title":"First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer\u2019s disease","volume":"45","author":"Martinez","year":"2002","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109051_bb0990","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1021\/jm034108b","article-title":"Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching","volume":"46","author":"Conde","year":"2003","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109051_bb0995","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109051_bb1000","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.chembiol.2003.12.009","article-title":"CDK versus GSK-3 inhibition: a purple haze no longer?","volume":"10","author":"Fischer","year":"2003","journal-title":"Chem. Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb1005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0960-894X(03)00135-5","article-title":"5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)","volume":"13","author":"Witherington","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb1010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jm031016d","article-title":"Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases","volume":"47","author":"Polychronopoulos","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109051_bb1015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 inhibitors: preclinical and clinical focus on CNS","volume":"4","author":"Eldar-Finkelman","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"29","key":"10.1016\/j.bioorg.2025.109051_bb1020","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.2174\/1381612823666170714141450","article-title":"GSK3 inhibitors in the therapeutic development of diabetes, Cancer and neurodegeneration: past, present and future","volume":"23","author":"Maqbool","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb1025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/diabetes.49.2.263","article-title":"Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes","volume":"49","author":"Nikoulina","year":"2000","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109051_bb1030","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0960-9822(02)70790-2","article-title":"Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells","volume":"6","author":"Stambolic","year":"1996","journal-title":"Curr. Biol\u202f: CB"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb1035","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/diab.38.5.648","article-title":"Normalization of insulin sensitivity with lithium in diabetic rats","volume":"38","author":"Rossetti","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2025.109051_bb1040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109051_bb1045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109051_bb1050","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1046\/j.1432-1033.2003.03777.x","article-title":"Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase","volume":"270","author":"MacAulay","year":"2003","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109051_bb1055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.50.5.937","article-title":"Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression","volume":"50","author":"Lochhead","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb1060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.bmcl.2004.12.063","article-title":"The development of potent and selective bisarylmaleimide GSK3 inhibitors","volume":"15","author":"Engler","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109051_bb1065","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/jm400511s","article-title":"Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis","volume":"56","author":"Gunosewoyo","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109051_bb1070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2012.12.014","article-title":"Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin","volume":"60","author":"Bidon-Chanal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb1075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem. Biol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109051_bb1080","article-title":"Structural insights into novel 15-prostaglandin dehydrogenase inhibitors","volume":"vol. 26","author":"Mallipeddi","year":"2021","journal-title":"Mol. (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.109051_bb1085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110707","article-title":"The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE(2)-EP4 receptor-AKT signaling in a type 2 diabetes mellitus mouse model","volume":"108","author":"Liang","year":"2023","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb1090","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2015.03.046","article-title":"Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core","volume":"25","author":"Sivaprakasam","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb1095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109051_bb1100","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109051_bb1105","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1021\/acs.jmedchem.7b00922","article-title":"Synthesis, binding mode, and Antihyperglycemic activity of potent and selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine inhibitors of glycogen synthase kinase 3","volume":"60","author":"Wagman","year":"2017","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109051_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126930","article-title":"Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors","volume":"30","author":"Ramurthy","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109051_bb1115","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2012.05.060","article-title":"Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3\u03b2 inhibitors","volume":"22","author":"Lee","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109051_bb1120","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/jm049768a","article-title":"Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3","volume":"47","author":"Engler","year":"2004","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109051_bb1125","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.bmc.2011.12.046","article-title":"Quinolone derivatives containing strained spirocycle as orally active glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) inhibitors for type 2 diabetics","volume":"20","author":"Seto","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109051_bb1130","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.bmc.2019.03.028","article-title":"Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3\u03b2 inhibitors","volume":"27","author":"Lozinskaya","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109051_bb1135","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1016\/j.bmcl.2014.10.078","article-title":"Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) with cellular activity of promoting glucose uptake","volume":"24","author":"Zhang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109051_bb1140","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/jm040895g","article-title":"SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors","volume":"48","author":"Martinez","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109051_bb1145","first-page":"131","article-title":"Genomics research: where are the drugs?","volume":"3","author":"Peet","year":"2000","journal-title":"IDrugs\u202f: Investigational Drugs J."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109051_bb1150","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm701582f","article-title":"9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication","volume":"51","author":"Stukenbrock","year":"2008","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109051_bb1155","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cmdc.202000183","article-title":"A dual inhibitor of DYRK1A and GSK3\u03b2 for \u03b2-cell proliferation: Aminopyrazine derivative GNF4877","volume":"15","author":"Liu","year":"2020","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109051_bb1160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/13543776.2020.1815706","article-title":"Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019)","volume":"30","author":"Roca","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109051_bb1165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","article-title":"Glycogen synthase kinase 3\u03b2: a new gold rush in anti-Alzheimer's disease multitarget drug discovery?","volume":"64","author":"De Simone","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:18:07Z","timestamp":1773861487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":233,"alternative-id":["S0045206825009319"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109051","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in targeting glycogen synthase kinase 3\u03b2 for diabetes therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109051"}}